Study Evaluating the Effect of Sirolimus on Non-Melanoma Skin Cancer in Kidney Transplant Recipients

NCT00129961 · clinicaltrials.gov ↗

PHASE4

Phase

COMPLETED

Status

86

Enrollment

INDUSTRY

Sponsor class

Conditions

Skin Neoplasms
Kidney Transplantation

Interventions

DRUG: sirolimus
DRUG: cyclosporine or tacrolimus

Sponsor

Wyeth is now a wholly owned subsidiary of Pfizer